Wells Fargo & Company »

Bioline Rx shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Bioline Rx (BLRX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Bioline Rx

Tip: Access up to 7 years of quarterly data

All positions including Bioline Rx held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioline Rx by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.6k 1.8k 3.78
2025-06-30 $8.0k 1.8k 4.57
2025-03-31 $8.9k 3.0k 2.96

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Bioline Rx

Susquehanna International
Citadel Advisors
Rhumbline Advisers
UBS Group
Wells Fargo & Company
Nemes Rush Group
Goss Wealth Management
Simplex Trading
Tower Research Capital
Rockefeller Capital Management
Danske Bank A/s
SBI Securities
Advisor Group Holdings

View all funds holding Bioline Rx